Literature DB >> 28075537

The comparative safety of buprenorphine versus methadone in pregnancy-what about confounding?

Susan B Brogly1, Kelley Saia2, Sonia Hernández-Diaz3, Martha Werler4, Paola Sebastiani5.   

Abstract

Entities:  

Keywords:  Birth outcomes; buprenorphine; infants; methadone; neonatal abstinence syndrome; pregnancy

Mesh：

Substances：

Year:  2016        PMID： 28075537      PMCID： PMC5571444          DOI： 10.1111/add.13551

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  16 in total

1.  Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome.

Authors:  Ursula A Pritham; Jonathan A Paul; Marie J Hayes
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2012-02-29

2.  Bias formulas for sensitivity analysis of unmeasured confounding for general outcomes, treatments, and confounders.

Authors:  Tyler J Vanderweele; Onyebuchi A Arah
Journal:  Epidemiology       Date:  2011-01       Impact factor: 4.822

3.  Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution.

Authors:  Claude Lejeune; Laurence Simmat-Durand; Laurent Gourarier; Sandrine Aubisson
Journal:  Drug Alcohol Depend       Date:  2005-10-27       Impact factor: 4.492

4.  Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study.

Authors:  Isabelle Lacroix; Alain Berrebi; Daniel Garipuy; Laurent Schmitt; Yamina Hammou; Catherine Chaumerliac; Maryse Lapeyre-Mestre; Jean-Louis Montastruc; Christine Damase-Michel
Journal:  Eur J Clin Pharmacol       Date:  2011-05-03       Impact factor: 2.953

5.  Neonatal abstinence syndrome after methadone or buprenorphine exposure.

Authors:  Hendrée E Jones; Karol Kaltenbach; Sarah H Heil; Susan M Stine; Mara G Coyle; Amelia M Arria; Kevin E O'Grady; Peter Selby; Peter R Martin; Gabriele Fischer
Journal:  N Engl J Med       Date:  2010-12-09       Impact factor: 91.245

6.  Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.

Authors:  Stephen W Patrick; Robert E Schumacher; Brian D Benneyworth; Elizabeth E Krans; Jennifer M McAllister; Matthew M Davis
Journal:  JAMA       Date:  2012-04-30       Impact factor: 56.272

7.  Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.

Authors:  Hendree E Jones; Rolley E Johnson; Donald R Jasinski; Kevin E O'Grady; Christian A Chisholm; Robin E Choo; Michael Crocetti; Robert Dudas; Cheryl Harrow; Marilyn A Huestis; Lauren M Jansson; Michael Lantz; Barry M Lester; Lorraine Milio
Journal:  Drug Alcohol Depend       Date:  2005-07       Impact factor: 4.492

8.  Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.

Authors:  Gabrielle K Welle-Strand; Svetlana Skurtveit; Hendreé E Jones; Helge Waal; Brittelise Bakstad; Lisa Bjarkø; Edle Ravndal
Journal:  Drug Alcohol Depend       Date:  2012-07-25       Impact factor: 4.492

9.  Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.

Authors:  Johan Kakko; Markus Heilig; Ihsan Sarman
Journal:  Drug Alcohol Depend       Date:  2008-03-19       Impact factor: 4.492

10.  Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.

Authors:  Brittelise Bakstad; Monica Sarfi; Gabrielle K Welle-Strand; Edle Ravndal
Journal:  Eur Addict Res       Date:  2009-03-31       Impact factor: 3.015
View more
  3 in total

1.  Naltrexone Treatment for Pregnant Women With Opioid Use Disorder Compared With Matched Buprenorphine Control Subjects.

Authors:  Elisha M Wachman; Kelley Saia; Melissa Miller; Eduardo Valle; Hira Shrestha; Ginny Carter; Martha Werler; Hendree Jones
Journal:  Clin Ther       Date:  2019-07-27       Impact factor: 3.393

2.  Examination of Hospital, Maternal, and Infant Characteristics Associated with Breastfeeding Initiation and Continuation Among Opioid-Exposed Mother-Infant Dyads.

Authors:  Davida M Schiff; Elisha M Wachman; Barbara Philipp; Kathleen Joseph; Hira Shrestha; Elsie M Taveras; Margaret G K Parker
Journal:  Breastfeed Med       Date:  2018-04-09       Impact factor: 1.817

3.  Medication for Addiction Treatment and Postpartum Health Care Utilization Among Pregnant Persons With Opioid Use Disorder.

Authors:  Katherine A Ahrens; Carole A McBride; Alane O'Connor; Marjorie C Meyer
Journal:  J Addict Med       Date:  2022 Jan-Feb 01       Impact factor: 3.702
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.